Last reviewed · How we verify

NCT06846593

The Comparison of Semiconductor Embedded Therapeutic Arm Sleeves for the Treatment of ECRB Tendinopathy

ENROLLING BY INVITATION NA Last updated 26 February 2025
What this trial tests

NA trial testing Semiconductor Embedded Therapeutic Arm Sleeves in ECRB Tendinopathy in 80 participants. Enrolling by invitation.

Timeline
1 November 2024
Primary endpoint
16 September 2025
1 November 2025

Quick facts

Lead sponsorINCREDIWEAR HOLDINGS, INC.
PhaseNA
StatusENROLLING BY INVITATION
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment80
Start date1 November 2024
Primary completion16 September 2025
Estimated completion1 November 2025
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

INCREDIWEAR HOLDINGS, INC. — full company profile →

Who can join

Adults 18 to 65, any sex, with ECRB Tendinopathy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study seeks to identify patient reported and clinically measured outcomes for pain management and elbow function with application of semiconductor embedded fabric combined with PRP+ASC injections in the affected area.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other INCREDIWEAR HOLDINGS, INC. trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06846593.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing